| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JSS.2006.09.027 |
| P698 | PubMed publication ID | 17583745 |
| P2093 | author name string | Ming Yang | |
| Tao Liu | |||
| Gang Zhao | |||
| Chunyou Wang | |||
| Tao Yin | |||
| Yunhong Zha | |||
| P433 | issue | 2 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 196-203 | |
| P577 | publication date | 2007-06-20 | |
| P1433 | published in | Journal of Surgical Research | Q15763329 |
| P1476 | title | Expression of snail in pancreatic cancer promotes metastasis and chemoresistance | |
| P478 | volume | 141 |
| Q37233401 | A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis |
| Q35212644 | Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors |
| Q84623806 | Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells |
| Q42128109 | BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen |
| Q38078237 | Biomarkers for predicting future metastasis of human gastrointestinal tumors. |
| Q38788205 | Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro |
| Q37072581 | Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions |
| Q44707530 | CCL2 is critical for immunosuppression to promote cancer metastasis |
| Q28066454 | Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis? |
| Q26740619 | Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment |
| Q35694314 | Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition |
| Q26864839 | Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention |
| Q84082530 | Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression |
| Q93040530 | Context-dependent EMT programs in cancer metastasis |
| Q53682858 | Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy. |
| Q58767409 | Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program |
| Q37661108 | ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition |
| Q46010223 | Effect of siRNA targeting HIF-1alpha combined L-ascorbate on biological behavior of hypoxic MiaPaCa2 cells. |
| Q46569803 | Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice |
| Q40167291 | Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells |
| Q37178822 | Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells |
| Q38679294 | Epithelial Mesenchymal Transition in Aggressive Lung Cancers |
| Q48146199 | Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review. |
| Q41438730 | Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths |
| Q38166588 | Epithelial-mesenchymal transition in pancreatic carcinoma |
| Q33902453 | Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma |
| Q90010888 | Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? |
| Q33700204 | Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer |
| Q34045380 | Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. |
| Q38572026 | Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells |
| Q41592725 | Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice |
| Q37729931 | Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways |
| Q40795286 | Gene expression profiles associated with advanced pancreatic cancer. |
| Q49723851 | Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury |
| Q28475586 | Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems |
| Q39104655 | Hypoxia-induced snail expression through transcriptional regulation by HIF-1α in pancreatic cancer cells |
| Q38827243 | Inhibition of perillyl alcohol on cell invasion and migration depends on the Notch signaling pathway in hepatoma cells |
| Q35002139 | Knockdown of snail sensitizes pancreatic cancer cells to chemotherapeutic agents and irradiation |
| Q54632531 | Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma |
| Q38929442 | MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway |
| Q38994193 | Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts. |
| Q37264732 | Metastatic progression is associated with dynamic changes in the local microenvironment |
| Q35161856 | Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis |
| Q38246499 | Molecular concepts in the pathogenesis of ameloblastoma: implications for therapeutics |
| Q36084344 | Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44. |
| Q35036615 | Overcoming drug resistance in pancreatic cancer. |
| Q50135698 | Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. |
| Q34140633 | Protein kinase D1 maintains the epithelial phenotype by inducing a DNA-bound, inactive SNAI1 transcriptional repressor complex |
| Q33719099 | Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer |
| Q37211351 | Reduced expression of Snail decreases breast cancer cell motility by downregulating the expression and inhibiting the activity of RhoA GTPase |
| Q33688924 | RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells |
| Q35073648 | Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling |
| Q38983127 | Snail cooperates with Kras G12D in vivo to increase stem cell factor and enhance mast cell infiltration |
| Q41859988 | Snail cooperates with KrasG12D to promote pancreatic fibrosis |
| Q37557751 | Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis |
| Q30434154 | Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma |
| Q92636854 | Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells |
| Q38786658 | Targeting metastasis |
| Q38242808 | Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer. |
| Q90451129 | The Expression of Snail, Galectin-3, and IGF1R in the Differential Diagnosis of Benign and Malignant Pheochromocytoma and Paraganglioma |
| Q39561486 | Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis |
| Q36596326 | miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance. |
Search more.